Treatment of gout with allopurinol and sulphinpyrazone in combination and with allopurinol alone.
D058186:Acute Kidney Injury / Q000188:drug therapy; D000328:Adult; D000368:Aged; D000493:Allopurinol / Q000009:adverse effects / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D002986:Clinical Trials as Topic; D004381:Duodenal Ulcer / Q000188:drug therapy; D057487:Enzyme Therapy; D005260:Female; D006073:Gout / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy; D013442:Sulfinpyrazone / Q000009:adverse effects / Q000627:therapeutic use*; D014527:Uric Acid / Q000097:blood / Q000652:urine; D014969:Xanthine Oxidase
D014527:Uric Acid; D000493:Allopurinol; D014969:Xanthine Oxidase; D013442:Sulfinpyrazone